Koyfin Home > Directory > Health Care > Amedisys Inc > Repurchase of Common Stock

Amedisys Inc Repurchase of Common Stock Chart (AMED)

Amedisys Inc annual/quarterly Repurchase of Common Stock from 2010 to 2020.
  • Amedisys Inc Repurchase of Common Stock for the quarter ending June 06, 2020 was $-2m a -109.73% increase of 3m year over year
  • Amedisys Inc Repurchase of Common Stock for the last 12 months ending June 06, 2020 was $-11m a 8.00% decrease of -1m year over year
  • Amedisys Inc Annual Repurchase of Common Stock for 2019 was $-10m a -1,867.06% increase of 178m from 2018
  • Amedisys Inc Annual Repurchase of Common Stock for 2018 was $-188m a 96.31% decrease of -181m from 2017
  • Amedisys Inc Annual Repurchase of Common Stock for 2017 was $-7m a -77.48% increase of 5m from 2016
Other Cash Flow Metrics:
  • Amedisys Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $64m a 37.04% increase of 24m year over year
  • Amedisys Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $47m a 41.63% increase of 20m year over year
  • Amedisys Inc Total Revenue for the quarter ending December 12, 2018 was $434m a 8.08% increase of 35m year over year
View Chart On Koyfin

Quarterly AMED Repurchase of Common Stock Data

06/2020$-2m
03/2020$-4m
12/2019$0m
09/2019$-5m
06/2019$-2m
03/2019$-3m
12/2018$-1m
09/2018$-3m
06/2018$-183m
03/2018$-1m

Annual AMED Repurchase of Common Stock Data

2019$-10m
2018$-188m
2017$-7m
2016$-12m
2015$-5m
2010$-12m